11 Feb 16

FDA said Thursday that it is new data, Amgen and Johnson & Johnson ‘s anemia drug Aranesp, Epogen and Procrit reported the risk of death and tumor growth in women with breast or cervical cancer, the Wall Street Journal can increase, show to check tratamiento de la disfunción eréctil . The drugs – known as erythropoiesis-stimulating agents – are caused by women to treat anemia treated by chemotherapy. FDA said it can additional measures based on two new studies of drugs. The agency last month by Amgen and Johnson & Johnson, according to the Journal Amgen is providing all three drugs and Procrit by by J & J’s Ortho Biotech unit. – According to the FDA, the two new studies are further evidence of the risks of anemia drugs, including rapid tumor growth or shortened survival in patients with breast, cervical and certain other cancers (Corbett Dooren, Wall Street Journal, The first study included 733 women, Los Angeles Times undergo chemotherapy before surgery to receive breast cancer to treat. Among the patients who received Aranesp their anemia, 14 percent had died after three years, compared to 9.8 percent of those who have not received Aranesp. Also tumors grew more rapidly in the patients who received Aranesp, according to the study.

If you are in a virtual brochure, which provides manufacturers, end-users are interested in, and other industry participants with an overview of the investment analysis and growth opportunities in the European Gastroenterology Therapeutics Market, then send an e-mail to Radhika Menon Theodore, Corporate Communications, by e-mailr full name, company name, telephone number, fax number, and e-mail address upon receipt of the above information, an overview will be sent to you by e-mail. The gastroenterology therapeutics market in Europe is proton pump proton pump inhibitors segment, says Frost & Sullivan Research Analyst John Paul Poor lifestyles continue to promote the inclusion of gastroenterology treatments and PPI. Efficacy efficacy, will contribute to revenue growth. .

Duke University in Co in – investigator: Scott Nash, Wesley Burks, discThe research to the the National Institutes of Health and the Foundation Eudowood.

After monitor, J sank the prevalence of HIV / AIDS of the early 1990 to 2000 the rate is said again on the rise may be. Moreover, the New Vision reported to care for 150,000 children living with HIV / AIDS in Uganda lag next behind care for adults, and Adeodata Kekitiinwa, the manager of the Baylor College of Medicine Children’s Foundation, that for the 133 health treatment of AIDS HIV / AIDS treatment for adults, is not only 32 such Kids. Museveni saying that on receive about 10,000 of the 150,000 children in distress from antiretroviral therapy, of them 40 percent received treatment by Baylor, mainly in urban areas. ‘We need to guarantee the equity resuscitation order to satisfy to children, ‘he added (New Vision.